mannitol has been researched along with Hypertension, Portal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borkar, VV; Kumari, N; Poddar, U; Roy, R; Singh, S; Yachha, SK | 1 |
| Carbonara, V; Cariello, R; Cartenì, M; Del Vecchio Blanco, C; Esposito, P; Federico, A; Loguercio, C; Martorelli, L; Miranda, A; Palasciano, G; Portincasa, P; Sapone, A; Scialdone, VR; Tiso, A; Tuccillo, C | 1 |
| Ferlitsch, A; Hayden, H; Heinisch, BB; Lammert, F; Mandorfer, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Trauner, M; Vogelsang, H | 1 |
| Hao, Z; Lin, N; Ling, YB; Tang, ZF; Xu, RY | 1 |
| Erickson, RA; Jonas, G; Morgan, T | 1 |
| Weinreich, J | 1 |
| Battung, V; DeWall, RA; Hirose, M; Najafi, H; Sarfatis, P | 1 |
1 trial(s) available for mannitol and Hypertension, Portal
| Article | Year |
|---|---|
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.
Topics: Adult; Atrophy; C-Reactive Protein; Cell Membrane Permeability; Drug Therapy, Combination; Female; Glutamine; Human Growth Hormone; Humans; Hypertension, Portal; Immunoglobulins; Interleukin-2; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Middle Aged; Proliferating Cell Nuclear Antigen; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
6 other study(ies) available for mannitol and Hypertension, Portal
| Article | Year |
|---|---|
Duodenal morphometry and small bowel permeability in children with portal hypertension.
Topics: Adolescent; Biopsy; Body Height; Body Weight; Case-Control Studies; Child; Constriction, Pathologic; Dietary Proteins; Duodenal Diseases; Duodenum; Energy Intake; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Mannitol; Nutritional Status; Permeability; Portal Vein; Prospective Studies; Skinfold Thickness; Vascular Diseases; Young Adult | 2015 |
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Topics: Adult; Age Factors; Aged; Alcoholism; Case-Control Studies; Diabetes Complications; Female; Hepatitis, Chronic; Humans; Hypertension, Portal; Interleukin-6; Intestinal Absorption; Lactulose; Liver Cirrhosis; Male; Mannitol; Middle Aged; Nitrites; S-Nitrosothiols; Tumor Necrosis Factor-alpha | 2010 |
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Topics: Acute-Phase Proteins; Adrenergic beta-Antagonists; Adult; Aged; Bacterial Translocation; Carrier Proteins; Cell Membrane Permeability; Comorbidity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Interleukin-6; Intestinal Absorption; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Mannitol; Membrane Glycoproteins; Middle Aged; Sucrose | 2013 |
Effect of portal hypertension on in vivo bile acid-mediated small intestinal mucosal injury in the rat.
Topics: Absorption; Animals; Bile Acids and Salts; Hypertension, Portal; Intestinal Mucosa; Intestine, Small; Mannitol; Microvilli; Perfusion; Rats; Water | 1990 |
[Portal hypertension in chronic liver diseases and its therapy].
Topics: Ascites; Chronic Disease; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Mannitol; Portacaval Shunt, Surgical; Spironolactone; Splenic Neoplasms; Thrombin | 1969 |
Hemodynamic changes associated with total body perfusion.
Topics: Animals; Blood Flow Velocity; Dextrans; Dogs; Female; Heart-Lung Machine; Hemodynamics; Hypertension, Portal; Male; Mannitol | 1966 |